There is also a dearth of data evaluating the safety of testosterone therapy in men treated with radiation therapy (RT). Product labels for all testosterone formulations explicitly state that their use is contraindicated in men with a history of prostate cancer, which results from Huggins' precept that testosterone therapy feeds prostate cancer cell proliferation. Studies were ineligible if they used supra-physiologic levels of testosterone or if participants were using androgens other than testosterone.
Across all studies, men had a mean baseline testosterone of 323 ng/dL, mean age of 59.9 years, and were followed for an average 34 weeks, during which time they were administered either a placebo or one of several testosterone modalities. A discussion regarding the benefit of stopping testosterone therapy should include the possibility of a decline in PSA. PSA recurrence in men on testosterone therapy should be evaluated in the same fashion as untreated men. There has been a concern that testosterone therapy might cause progression of previously existing, but undiagnosed, prostate cancer or that testosterone might cause high-grade prostatic intraepithelial neoplasias (PIN) to progress into frank carcinoma. There are limited data in men on active surveillance who are candidates for testosterone therapy.
Patients with testosterone deficiency who maintain testosterone levels in the normal range while on testosterone therapy should have their PSA levels tested, utilizing a shared decision-making approach, in accordance with the AUA's Early Detection of Prostate Cancer Guideline. It is the opinion of this Panel that serum PSA levels should be measured prior to the commencement of testosterone therapy in patients over 40 years of age in order to minimize the risk of prescribing testosterone therapy to men with occult prostate cancer. Specifically, the odds ratio for developing ED in men with total testosterone 6 used a single question to define ED and also showed an increase in ED risk as total testosterone levels decreased. In a small study of young men with acute respiratory infections, mean total testosterone levels declined by 10%, with some cohorts experiencing reductions of up to 30%.25
We accepted whatever criteria were used by individual study authors to define low testosterone. For clinical endpoints only (angina/ischemia, congestive heart failure, and erectile dysfunction) we also included an analysis of studies restricted to Jadad scores of 4 or 5. Data were extracted into tables by 4 independent reviewers according to the presence of information on cardiovascular health, sexual function, muscle weakness/wasting, mood and behavior, or cognition. We did not include studies on the use of testosterone for any indication in women or in children, the use of androgens in contraception, or the use of androgens for bodybuilding or athletic performance.
The validated instruments include ADAM, Quantitative ADAM, Aging Male Survey (AMS), MMAS, and the ANDROTEST.10, 166, 167 Specificities and sensitivities vary greatly amongst these tests making them ill-suited for screening or for use as a surrogate for testosterone laboratory testing. Depending upon the radiation dose, delivery modality, and underlying tumor type, LH deficiency rates in patients whose pituitary gland has been exposed to radiation is 10-96%.160 Large pituitary tumors, functioning or non-functioning, may require surgical extirpation because of mass effect. The contemporary management of functioning prolactin secreting tumors is the use of medications, such as bromocriptine and cabergoline. Serum testosterone and the downstream hormone E2 are involved in the feedback mechanism to the hypothalamus and pituitary to suppress LH production. The pituitary gland sits in the sella turcica below the cerebrum and plays a critical role in testosterone physiology by producing luteinizing hormone (LH), which targets the Leydig cells in the testes stimulating them to produce testosterone. While Leydig cells are less radiosensitive than germ cells, radiation exposure to the testis can impair testosterone production.
Nine of the 14 studies that lacked favorable effects on lipids had Jadad scores of 4 or 5. Nine of the 11 studies that had favorable effects on lipids had Jadad scores of 4 or 5. One of these studies reported a decrease in lipoprotein-a (LP-a), but this finding was transient and occurred in a study with multiple measurements at multiple time points in multiple patient subgroups without adjustment for multiple comparisons. One of the studies counted as showing a favorable effect did not demonstrate a change in total or high-density lipoprotein (HDL) cholesterol or triglycerides but reported a 13% reduction in LDL cholesterol. Another study of IM testosterone in men with CHF showed an improvement in oxygen consumption, respiratory efficiency (ventilation/carbon dioxide consumption), and distance walked in 10 minutes without changes in EF or left ventricular end-diastolic diameter. Some studies included identical numbers of subjects in treatment and exposed conditions, suggesting that allocation was not random.
But if you have other symptoms, you’ll want to see your doctor. Swerdloff says you should get multiple tests -- at least two over the course of a couple of weeks or months. Low testosterone -- also known as hypogonadism or low T -- can affect your overall health.
Having the best trt clinic and licensed medical providers to guide you is crucial to getting the most from your therapy. With daily injections, most people experience fewer side effects and avoid the ups and downs of weekly injections. The choice between different injection frequencies and the best time to inject testosterone depends on individual preferences and medical recommendations. One of the common questions guys on TRT face is when is the best time of day to inject testosterone? Testosterone is a hormone produced primarily in the testicles in males and, to a lesser extent, in the ovaries in females.

Gender: Female

Social links